This research investigates taste alterations experienced by cancer patients during chemotherapy and radiotherapy. Using electrogustometry and flavour profile analysis, the study measures and categorizes changes in taste perception to guide the development of tailored food products that improve nutrition, comfort, and quality of life for people undergoing cancer treatment.

This research investigates whether regeneration can be induced in animals that normally lack regenerative abilities. Using nutrient factors such as amino acids and insulin, regeneration was stimulated in mice, jellyfish, and fruit flies. The findings reveal that regeneration is a coordinated whole-body process involving energy allocation, organ remodeling, and conserved nutrient signaling pathways.

This research investigates asthma’s underlying mechanisms, focusing on airway fibrosis and the extracellular matrix. Using Raman spectroscopy, researchers generate molecular “barcodes” of lung tissue. Artificial intelligence is then applied to analyze complex data, aiming to identify key biological drivers of asthma and move beyond temporary treatments toward deeper understanding and potential long-term solutions.

This research investigates the protein SLX4, a key coordinator of DNA repair. Using complementary techniques, it identifies 221 interacting proteins, most previously unknown. Findings reveal a complex network involved in genome maintenance, offering new insights into cellular repair mechanisms and improving understanding of diseases such as cancer.

This research targets rare genetic diseases caused by frameshift mutations using antisense oligonucleotides as “genetic band-aids.” By masking faulty DNA segments, it restores functional protein production. Demonstrated in muscular dystrophy models, this approach offers a scalable strategy to treat multiple rare diseases, addressing a major gap where most conditions lack effective therapies.

This research develops a hybrid drug for dry age-related macular degeneration, combining anti-inflammatory and antioxidant mechanisms. By targeting both inflammation and oxidative stress, it aims to slow disease progression more effectively than existing treatments. Laboratory models test whether the combined therapy outperforms individual or co-administered components in preserving retinal function.

This research explores how immune-related cells and molecules, beneficial in wound healing, may become harmful in Parkinson’s disease. Using the fruit fly as a model organism, the study investigates which inflammatory processes contribute to brain damage. Early results suggest that excessive activation worsens degeneration, offering potential targets for future therapies.